{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,21]],"date-time":"2026-11-21T06:09:49Z","timestamp":1795241389928,"version":"4.10.3"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81871175"],"award-info":[{"award-number":["81871175"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"DOI":"10.1186\/s12884-025-07243-6","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T08:08:45Z","timestamp":1740730125000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Glycosylated fibronectin in preeclampsia: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"25","author":[{"given":"Lingyun","family":"Liao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangxue","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liming","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangshuang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,28]]},"reference":[{"issue":"6","key":"7243_CR1","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1097\/AOG.0000000000003892","volume":"135","author":"Gestational Hypertension and Preeclampsia","year":"2020","unstructured":"Gestational Hypertension and Preeclampsia. ACOG Practice Bulletin Summary, Number 222. Obstet Gynecol. 2020;135(6):1492\u20135.","journal-title":"Obstet Gynecol"},{"issue":"14","key":"7243_CR2","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1016\/j.jacc.2020.08.014","volume":"76","author":"CW Ives","year":"2020","unstructured":"Ives CW, Sinkey R, Rajapreyar I, Tita ATN, Oparil S. Preeclampsia-Pathophysiology and Clinical presentations: JACC State-of-the-art review. J Am Coll Cardiol. 2020;76(14):1690\u2013702.","journal-title":"J Am Coll Cardiol"},{"issue":"10297","key":"7243_CR3","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/S0140-6736(20)32335-7","volume":"398","author":"LC Chappell","year":"2021","unstructured":"Chappell LC, Cluver CA, Kingdom J, Tong S. Pre-eclampsia. Lancet. 2021;398(10297):341\u201354.","journal-title":"Lancet"},{"key":"7243_CR4","doi-asserted-by":"crossref","unstructured":"Dennehy N, Lees C, Preeclampsia. Maternal cardiovascular function and optimising outcomes. Early Hum Dev. 2022;174:105669.","DOI":"10.1016\/j.earlhumdev.2022.105669"},{"issue":"1","key":"7243_CR5","doi-asserted-by":"publisher","first-page":"e2145719","DOI":"10.1001\/jamanetworkopen.2021.45719","volume":"5","author":"L Kong","year":"2022","unstructured":"Kong L, Chen X, Liang Y, Forsell Y, Gissler M, Lavebratt C. Association of Preeclampsia and Perinatal complications with offspring Neurodevelopmental and Psychiatric disorders. JAMA Netw Open. 2022;5(1):e2145719.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"7243_CR6","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.bpa.2022.02.003","volume":"36","author":"E Overton","year":"2022","unstructured":"Overton E, Tobes D, Lee A. Preeclampsia diagnosis and management. Best Pract Res Clin Anaesthesiol. 2022;36(1):107\u201321.","journal-title":"Best Pract Res Clin Anaesthesiol"},{"issue":"7","key":"7243_CR7","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1161\/CIRCRESAHA.118.313276","volume":"124","author":"S Rana","year":"2019","unstructured":"Rana S, Lemoine E, Granger JP, Karumanchi SA. Preeclampsia: pathophysiology, challenges, and perspectives. Circ Res. 2019;124(7):1094\u2013112.","journal-title":"Circ Res"},{"issue":"5","key":"7243_CR8","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/s41581-019-0119-6","volume":"15","author":"EA Phipps","year":"2019","unstructured":"Phipps EA, Thadhani R, Benzing T, Karumanchi SA. Pre-eclampsia: pathogenesis, novel diagnostics and therapies. Nat Rev Nephrol. 2019;15(5):275\u201389.","journal-title":"Nat Rev Nephrol"},{"key":"7243_CR9","doi-asserted-by":"publisher","first-page":"103780","DOI":"10.1016\/j.ebiom.2021.103780","volume":"75","author":"TM MacDonald","year":"2022","unstructured":"MacDonald TM, Walker SP, Hannan NJ, Tong S, Kaitu\u2019u-Lino TJ. Clinical tools and biomarkers to predict preeclampsia. EBioMedicine. 2022;75:103780.","journal-title":"EBioMedicine"},{"key":"7243_CR10","doi-asserted-by":"publisher","first-page":"883404","DOI":"10.3389\/fimmu.2022.883404","volume":"13","author":"Y Wang","year":"2022","unstructured":"Wang Y, Li B, Zhao Y. Inflammation in Preeclampsia: genetic biomarkers, mechanisms, and therapeutic strategies. Front Immunol. 2022;13:883404.","journal-title":"Front Immunol"},{"issue":"4","key":"7243_CR11","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1161\/HYPERTENSIONAHA.119.13763","volume":"75","author":"H Stepan","year":"2020","unstructured":"Stepan H, Hund M, Andraczek T. Combining biomarkers to predict pregnancy complications and redefine Preeclampsia: the angiogenic-placental syndrome. Hypertension. 2020;75(4):918\u201326.","journal-title":"Hypertension"},{"issue":"2","key":"7243_CR12","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/uog.26032","volume":"61","author":"H Stepan","year":"2023","unstructured":"Stepan H, Galindo A, Hund M, Schlembach D, Sillman J, Surbek D, Vatish M. Clinical utility of sFlt-1 and PlGF in screening, prediction, diagnosis and monitoring of pre-eclampsia and fetal growth restriction. Ultrasound Obstet Gynecol. 2023;61(2):168\u201380.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"6","key":"7243_CR13","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1097\/AOG.0b013e3181dd5137","volume":"115","author":"B Thilaganathan","year":"2010","unstructured":"Thilaganathan B, Wormald B, Zanardini C, Sheldon J, Ralph E, Papageorghiou AT. Early-pregnancy multiple serum markers and second-trimester uterine artery Doppler in predicting preeclampsia. Obstet Gynecol. 2010;115(6):1233\u20138.","journal-title":"Obstet Gynecol"},{"key":"7243_CR14","doi-asserted-by":"crossref","unstructured":"Ridder A, Giorgione V, Khalil A, Thilaganathan B, Preeclampsia. The relationship between Uterine Artery Blood Flow and trophoblast function. Int J Mol Sci. 2019;20(13).","DOI":"10.3390\/ijms20133263"},{"issue":"2","key":"7243_CR15","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1055\/a-2075-3021","volume":"45","author":"M La Verde","year":"2024","unstructured":"La Verde M, Torella M, Ronsini C, Riemma G, Cobellis L, Marrapodi MM, et al. The association between fetal doppler and uterine artery blood volume flow in term pregnancies: a pilot study. Ultraschall Med. 2024;45(2):184\u20139.","journal-title":"Ultraschall Med"},{"issue":"2","key":"7243_CR16","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1161\/HYPERTENSIONAHA.117.10182","volume":"71","author":"S Agrawal","year":"2018","unstructured":"Agrawal S, Cerdeira AS, Redman C, Vatish M. Meta-analysis and systematic review to assess the role of Soluble FMS-Like Tyrosine Kinase-1 and placenta growth factor ratio in prediction of Preeclampsia: the SaPPPhirE Study. Hypertension. 2018;71(2):306\u201316.","journal-title":"Hypertension"},{"issue":"7","key":"7243_CR17","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1161\/HYPERTENSIONAHA.123.22584","volume":"81","author":"P Guerby","year":"2024","unstructured":"Guerby P, Audibert F, Johnson JA, Okun N, Gigu\u00e8re Y, Forest JC, et al. Prospective validation of First-Trimester Screening for Preterm Preeclampsia in Nulliparous Women (PREDICTION Study). Hypertension. 2024;81(7):1574\u201382.","journal-title":"Hypertension"},{"issue":"1","key":"7243_CR18","doi-asserted-by":"publisher","first-page":"e821","DOI":"10.1016\/j.ajog.2014.07.052","volume":"212","author":"J Rasanen","year":"2015","unstructured":"Rasanen J, Quinn MJ, Laurie A, Bean E, Roberts CT Jr., Nagalla SR, Gravett MG. Maternal serum glycosylated fibronectin as a point-of-care biomarker for assessment of preeclampsia. Am J Obstet Gynecol. 2015;212(1):e821\u20139.","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"7243_CR19","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s12884-020-2809-2","volume":"20","author":"EA Huhn","year":"2020","unstructured":"Huhn EA, Hoffmann I, Martinez De Tejada B, Lange S, Sage KM, Roberts CT, et al. Maternal serum glycosylated fibronectin as a short-term predictor of preeclampsia: a prospective cohort study. BMC Pregnancy Childbirth. 2020;20(1):128.","journal-title":"BMC Pregnancy Childbirth"},{"issue":"13","key":"7243_CR20","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1111\/1471-0528.16323","volume":"127","author":"SR Nagalla","year":"2020","unstructured":"Nagalla SR, Janaki V, Vijayalakshmi AR, Chayadevi K, Pratibha D, Rao PV, et al. Glycosylated fibronectin point-of-care test for diagnosis of pre-eclampsia in a low-resource setting: a prospective southeast Asian population study. BJOG. 2020;127(13):1687\u201394.","journal-title":"BJOG"},{"issue":"5","key":"7243_CR21","doi-asserted-by":"publisher","first-page":"e23740","DOI":"10.1002\/jcla.23740","volume":"35","author":"J Wang","year":"2021","unstructured":"Wang J, Hu H, Liu X, Zhao S, Zheng Y, Jia Z, et al. Predictive values of various serum biomarkers in women with suspected preeclampsia: a prospective study. J Clin Lab Anal. 2021;35(5):e23740.","journal-title":"J Clin Lab Anal"},{"issue":"Suppl 1","key":"7243_CR22","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s13224-021-01566-y","volume":"72","author":"S Kesireddy","year":"2022","unstructured":"Kesireddy S, Reddy P, Gayathri V, Reddy P, Reddy B. Glycosylated Fibronectin Point-of-care test for triage and surveillance of hypertension in pregnancy cases: a Retrospective Observational Case Control Study. J Obstet Gynaecol India. 2022;72(Suppl 1):121\u20135.","journal-title":"J Obstet Gynaecol India"},{"issue":"4","key":"7243_CR23","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/uog.27451","volume":"62","author":"S Moungmaithong","year":"2023","unstructured":"Moungmaithong S, Wang X, Lau CSL, Tse AWT, Lee NMW, Leung HHY, et al. Glycosylated fibronectin improves first-trimester prediction of pre-eclampsia. Ultrasound Obstet Gynecol. 2023;62(4):512\u201321.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"4","key":"7243_CR24","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1002\/uog.26303","volume":"62","author":"N Sokratous","year":"2023","unstructured":"Sokratous N, Bednorz M, Sarli P, Morillo Montes OE, Syngelaki A, Wright A, Nicolaides KH. Screening for pre-eclampsia by maternal serum glycosylated fibronectin at 11\u201313 weeks\u2019 gestation. Ultrasound Obstet Gynecol. 2023;62(4):504\u201311.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"6","key":"7243_CR25","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1002\/uog.27475","volume":"62","author":"N Sokratous","year":"2023","unstructured":"Sokratous N, Bednorz M, Syngelaki A, Wright A, Nicolaides KH, Kametas NA. Prediction using serum glycosylated fibronectin and angiogenic factors of superimposed pre-eclampsia in women with chronic hypertension. Ultrasound Obstet Gynecol. 2023;62(6):836\u201342.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"5","key":"7243_CR26","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1002\/uog.27458","volume":"62","author":"N Sokratous","year":"2023","unstructured":"Sokratous N, Bednorz M, Wright A, Nicolaides KH, Kametas NA. Prediction using serum glycosylated fibronectin of imminent pre-eclampsia in women with new-onset hypertension. Ultrasound Obstet Gynecol. 2023;62(5):653\u20139.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"1","key":"7243_CR27","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/uog.27481","volume":"63","author":"N Sokratous","year":"2024","unstructured":"Sokratous N, Wright A, Syngelaki A, Kakouri E, Laich A, Nicolaides KH. Screening for pre-eclampsia by maternal serum glycosylated fibronectin and angiogenic markers at 36 weeks\u2019 gestation. Ultrasound Obstet Gynecol. 2024;63(1):88\u201397.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"12","key":"7243_CR28","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1093\/glycob\/cwj019","volume":"15","author":"M Tajiri","year":"2005","unstructured":"Tajiri M, Yoshida S, Wada Y. Differential analysis of site-specific glycans on plasma and cellular fibronectins: application of a hydrophilic affinity method for glycopeptide enrichment. Glycobiology. 2005;15(12):1332\u201340.","journal-title":"Glycobiology"},{"issue":"1","key":"7243_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2046-4053-4-1","volume":"4","author":"D Moher","year":"2015","unstructured":"Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4(1):1.","journal-title":"Syst Rev"},{"key":"7243_CR30","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.preghy.2021.09.008","volume":"27","author":"LA Magee","year":"2022","unstructured":"Magee LA, Brown MA, Hall DR, Gupte S, Hennessy A, Karumanchi SA, et al. The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis & management recommendations for international practice. Pregnancy Hypertens. 2022;27:148\u201369.","journal-title":"Pregnancy Hypertens"},{"issue":"9","key":"7243_CR31","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","volume":"25","author":"A Stang","year":"2010","unstructured":"Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603\u20135.","journal-title":"Eur J Epidemiol"},{"key":"7243_CR32","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.jclinepi.2019.12.013","volume":"120","author":"A Moskalewicz","year":"2020","unstructured":"Moskalewicz A, Oremus M. No clear choice between Newcastle-Ottawa Scale and Appraisal Tool for cross-sectional studies to assess methodological quality in cross-sectional studies of health-related quality of life and breast cancer. J Clin Epidemiol. 2020;120:94\u2013103.","journal-title":"J Clin Epidemiol"},{"issue":"8","key":"7243_CR33","doi-asserted-by":"publisher","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","volume":"155","author":"PF Whiting","year":"2011","unstructured":"Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155(8):529\u201336.","journal-title":"Ann Intern Med"},{"issue":"4","key":"7243_CR34","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","volume":"64","author":"G Guyatt","year":"2011","unstructured":"Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64(4):383\u201394.","journal-title":"J Clin Epidemiol"},{"key":"7243_CR35","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1471-2288-14-135","volume":"14","author":"X Wan","year":"2014","unstructured":"Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range. BMC Med Res Methodol. 2014;14:135.","journal-title":"BMC Med Res Methodol"},{"issue":"6","key":"7243_CR36","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1177\/0962280216669183","volume":"27","author":"D Luo","year":"2018","unstructured":"Luo D, Wan X, Liu J, Tong T. Optimally estimating the sample mean from the sample size, median, mid-range, and\/or mid-quartile range. Stat Methods Med Res. 2018;27(6):1785\u2013805.","journal-title":"Stat Methods Med Res"},{"issue":"2","key":"7243_CR37","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.cll.2023.02.002","volume":"43","author":"DA Ortiz","year":"2023","unstructured":"Ortiz DA, Loeffelholz MJ. Practical challenges of Point-of-care testing. Clin Lab Med. 2023;43(2):155\u201365.","journal-title":"Clin Lab Med"},{"issue":"7\u20138","key":"7243_CR38","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1080\/10408363.2017.1399336","volume":"54","author":"C Florkowski","year":"2017","unstructured":"Florkowski C, Don-Wauchope A, Gimenez N, Rodriguez-Capote K, Wils J, Zemlin A. Point-of-care testing (POCT) and evidence-based laboratory medicine (EBLM) - does it leverage any advantage in clinical decision making? Crit Rev Clin Lab Sci. 2017;54(7\u20138):471\u201394.","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"1","key":"7243_CR39","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1515\/ijb-2020-0091","volume":"18","author":"P Mart\u00ednez-Camblor","year":"2021","unstructured":"Mart\u00ednez-Camblor P, P\u00e9rez-Fern\u00e1ndez S, D\u00edaz-Coto S. The area under the generalized receiver-operating characteristic curve. Int J Biostat. 2021;18(1):293\u2013306.","journal-title":"Int J Biostat"},{"issue":"1","key":"7243_CR40","doi-asserted-by":"publisher","first-page":"25","DOI":"10.4097\/kja.21209","volume":"75","author":"FS Nahm","year":"2022","unstructured":"Nahm FS. Receiver operating characteristic curve: overview and practical use for clinicians. Korean J Anesthesiol. 2022;75(1):25\u201336.","journal-title":"Korean J Anesthesiol"},{"issue":"4","key":"7243_CR41","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1515\/cclm-2020-0477","volume":"59","author":"P L\u00e9vy","year":"2021","unstructured":"L\u00e9vy P, Hamdi S, Guiboudenche J, Haguet MC, Bailleul S, Lef\u00e8vre G. Applying the concept of uncertainty to the sFlt-1\/PlGF cut-offs for diagnosis and prognosis of preeclampsia. Clin Chem Lab Med. 2021;59(4):681\u20136.","journal-title":"Clin Chem Lab Med"},{"key":"7243_CR42","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.preghy.2021.12.003","volume":"27","author":"S Verlohren","year":"2022","unstructured":"Verlohren S, Brennecke SP, Galindo A, Karumanchi SA, Mirkovic LB, Schlembach D, et al. Clinical interpretation and implementation of the sFlt-1\/PlGF ratio in the prediction, diagnosis and management of preeclampsia. Pregnancy Hypertens. 2022;27:42\u201350.","journal-title":"Pregnancy Hypertens"},{"issue":"2","key":"7243_CR43","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1006\/excr.1995.1374","volume":"221","author":"C ffrench-Constant","year":"1995","unstructured":"ffrench-Constant C. Alternative splicing of fibronectin\u2013many different proteins but few different functions. Exp Cell Res. 1995;221(2):261\u201371.","journal-title":"Exp Cell Res"},{"issue":"Pt 20","key":"7243_CR44","doi-asserted-by":"publisher","first-page":"3861","DOI":"10.1242\/jcs.00059","volume":"115","author":"R Pankov","year":"2002","unstructured":"Pankov R, Yamada KM. Fibronectin at a glance. J Cell Sci. 2002;115(Pt 20):3861\u20133.","journal-title":"J Cell Sci"},{"issue":"7","key":"7243_CR45","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1161\/ATVBAHA.108.181081","volume":"29","author":"HY Chiang","year":"2009","unstructured":"Chiang HY, Korshunov VA, Serour A, Shi F, Sottile J. Fibronectin is an important regulator of flow-induced vascular remodeling. Arterioscler Thromb Vasc Biol. 2009;29(7):1074\u20139.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"7243_CR46","doi-asserted-by":"crossref","unstructured":"DiPrisco B, Kumar A, Kalra B, Savjani GV, Michael Z, Farr O, GLYCOSYLATED FIBRONECTIN AND INHIBIN ARE LOWER AND ANTI-M\u00dcLLERIAN HORMONE IS HIGHER IN UMBILICAL CORD BLOOD WHEN MOTHERS HAVE PREECLAMPSIA, et al. Endocr Pract. 2020;26(3):318\u201327.","DOI":"10.4158\/EP-2019-0448"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-025-07243-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-025-07243-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-025-07243-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T08:43:03Z","timestamp":1740732183000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-025-07243-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,28]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7243"],"URL":"https:\/\/doi.org\/10.1186\/s12884-025-07243-6","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,28]]},"assertion":[{"value":"26 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"228"}}